Literature DB >> 23743127

γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis.

Ying Zhu1, Irina Haecker, Yajie Yang, Shou-Jiang Gao, Rolf Renne.   

Abstract

To date, more than 200 viral miRNAs have been identified mostly from herpesviruses and this rapidly evolving field has recently been summarized in a number of excellent reviews (see [1,2]). Unique to γ-herpesviruses, like Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus, is their ability to cause cancer. Here, we discuss γ-herpesvirus-encoded miRNAs and focus on recent findings which support the hypothesis that viral miRNAs directly contribute to pathogenesis and tumorigenesis. The observations that KSHV mimics a human tumorigenic miRNA (hsa-miR-155), which is induced in EBV-infected cells and required for the survival of EBV-immortalized cells, lead to a number of studies demonstrating that perturbing this pathway induces B cell proliferation in vivo and immortalization of human B cells in vitro. Secondly, the application of state of the art ribonomics methods to globally identify viral miRNA targets in virus-infected tumor cells provides a rich resource to the KSHV and EBV fields and largely expanded our understanding on how viral miRNAs contribute to viral biology.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23743127      PMCID: PMC3879080          DOI: 10.1016/j.coviro.2013.05.013

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  79 in total

1.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

2.  Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.

Authors:  Xuezhong Cai; Shihua Lu; Zhihong Zhang; Carlos M Gonzalez; Blossom Damania; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

3.  Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus.

Authors:  Mark A Samols; Jianhong Hu; Rebecca L Skalsky; Rolf Renne
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses.

Authors:  Adam Grundhoff; Christopher S Sullivan; Don Ganem
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

5.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

Authors:  Stefan Costinean; Nicola Zanesi; Yuri Pekarsky; Esmerina Tili; Stefano Volinia; Nyla Heerema; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

6.  A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest.

Authors:  Eva Gottwein; Bryan R Cullen
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

7.  Comprehensive analysis of Rhesus lymphocryptovirus microRNA expression.

Authors:  Kasandra J-L Riley; Gabrielle S Rabinowitz; Joan A Steitz
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

8.  Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus.

Authors:  Sanjay Chandriani; Don Ganem
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

9.  Identification of microRNAs of the herpesvirus family.

Authors:  Sébastien Pfeffer; Alain Sewer; Mariana Lagos-Quintana; Robert Sheridan; Chris Sander; Friedrich A Grässer; Linda F van Dyk; C Kiong Ho; Stewart Shuman; Minchen Chien; James J Russo; Jingyue Ju; Glenn Randall; Brett D Lindenbach; Charles M Rice; Viviana Simon; David D Ho; Mihaela Zavolan; Thomas Tuschl
Journal:  Nat Methods       Date:  2005-02-16       Impact factor: 28.547

10.  Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay.

Authors:  Lars Dölken; Georg Malterer; Florian Erhard; Sheila Kothe; Caroline C Friedel; Guillaume Suffert; Lisa Marcinowski; Natalie Motsch; Stephanie Barth; Michaela Beitzinger; Diana Lieber; Susanne M Bailer; Reinhard Hoffmann; Zsolt Ruzsics; Elisabeth Kremmer; Sébastien Pfeffer; Ralf Zimmer; Ulrich H Koszinowski; Friedrich Grässer; Gunter Meister; Jürgen Haas
Journal:  Cell Host Microbe       Date:  2010-04-22       Impact factor: 21.023

View more
  47 in total

Review 1.  Virus meets host microRNA: the destroyer, the booster, the hijacker.

Authors:  Yang Eric Guo; Joan A Steitz
Journal:  Mol Cell Biol       Date:  2014-07-21       Impact factor: 4.272

Review 2.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

3.  Kaposi's sarcoma-associated herpesvirus downregulates transforming growth factor β2 to promote enhanced stability of capillary-like tube formation.

Authors:  Terri A DiMaio; Kimberley D Gutierrez; Michael Lagunoff
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 4.  Viral microRNA genomics and target validation.

Authors:  Joseph M Ziegelbauer
Journal:  Curr Opin Virol       Date:  2014-04-22       Impact factor: 7.090

5.  Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses.

Authors:  Jennifer E Cox; Lydia V McClure; Andrei Goga; Christopher S Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

Review 6.  Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.

Authors:  Denis Avey; Brittany Brewers; Fanxiu Zhu
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

7.  Inefficient Codon Usage Impairs mRNA Accumulation: the Case of the v-FLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Priya Bellare; Andrew Dufresne; Don Ganem
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 8.  New insights into the expression and functions of the Kaposi's sarcoma-associated herpesvirus long noncoding PAN RNA.

Authors:  Nicholas K Conrad
Journal:  Virus Res       Date:  2015-06-21       Impact factor: 3.303

9.  Kaposi sarcoma-associated herpesvirus miRNAs suppress CASTOR1-mediated mTORC1 inhibition to promote tumorigenesis.

Authors:  Tingting Li; Enguo Ju; Shou-Jiang Gao
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

Review 10.  Immune escape of γ-herpesviruses from adaptive immunity.

Authors:  Zhuting Hu; Edward J Usherwood
Journal:  Rev Med Virol       Date:  2014-04-15       Impact factor: 6.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.